newsfilter
← Latest News
GlobeNewswire·

BioNTech Announces First Quarter 2026 Financial Results and Corporate Update

Five additional pivotal trials for pumitamig initiated during 2026 in collaboration with Bristol Myers SquibbOncology pipeline strength and combination strategy highlighted through multiple clinical data updates,